Director of Analytical Development
Dragonfly Therapeutics is seeking a Director of Analytical Development to join our team. Responsibilities include the development, optimization, and tech transfer of analytical assays for release and characterization testing of clinical-stage bispecific antibodies, cytokines, and other protein-based therapeutics, with a focus on pivotal readiness. Additional duties involve authoring and reviewing CMC sections of regulatory filings and supporting documents. Collaboration with cross-functional teams is essential to ensure the successful execution of analytical workstreams and QC testing.
As a subject matter expert in analytical assay development for novel biologics, with a strong understanding of CMC cross-functional dynamics, you will be expected to provide strategic leadership and direction for analytical development activities. We are seeking a candidate with deep technical expertise in separations, mass spectrometry, biophysical and biochemical analyses. In this role, you will work closely with research, process development, manufacturing, regulatory, and quality teams to innovate and advance Dragonfly’s next-generation products. This is a unique opportunity for a dynamic leader to contribute their expertise as Dragonfly advances its clinical development portfolio.
Responsibilities (including but not limited to):
Qualifications:
About Dragonfly
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas.
Our mission is to revolutionize disease treatment by inventing natural killer cell-based therapies for vastly improved patient outcomes. We believe in a small team with a big impact.